Although our previous studies have suggested the deacetylase activity of SIRT3 in modulating mitochondria ROS and oxidative phosphorylation altered the chemo-sensitivity of AML to a chemotherapeutic agent, an increasing number of studies demonstrated a new role of SIRT3 in transcriptional regulation. Here, SIRT3 is linked to acute myeloid leukemia.